Related Experiment Video
Updated: May 9, 2025

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Litigation of unlicensed US stem cell products.
Branden Lee1, Noah Brookes2, Adam S Levin3
1Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA; Department of Orthopaedic Surgery, The Johns Hopkins Hospital, 601 N. Caroline Street, Suite 5251, Baltimore, MD 21287, USA.
Financial penalties for unapproved stem cell therapies are increasing, alongside court affirmations of the Food and Drug Administration's (FDA) regulatory power over these treatments. This establishes key precedents for oversight.
Area of Science:
- Biomedical Law
- Regulatory Science
- Stem Cell Therapeutics
Background:
- Unapproved stem cell interventions pose significant risks to patients.
- There has been a notable increase in legal and financial actions against providers of unproven stem cell treatments.
Purpose of the Study:
- To analyze the trend of financial dispositions against unapproved stem cell interventions.
- To examine the legal precedents set regarding the Food and Drug Administration's (FDA) regulatory authority over stem cell therapies.
Main Methods:
- Review of legal dockets and financial disposition data.
- Analysis of federal circuit court rulings concerning FDA oversight of stem cell interventions.
Main Results:
- Significant growth in financial penalties, including class-action lawsuits and malpractice claims.
- Unanimous federal circuit court affirmations of the FDA's regulatory authority.
Conclusions:
- The legal and regulatory landscape is increasingly unfavorable to unapproved stem cell interventions.
- Established court precedents strengthen the FDA's oversight capabilities, enhancing patient protection.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Clinical Applications of Epidermal Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Adult Stem Cells
Induced Pluripotent Stem Cells
Somatic...

